Comparisons of Clinical Features in Japanese Patients with Behçet’s Uveitis Treated in the 1990s and the 2000s

References

• Namba K, Goto H, Kaburaki T, et al. A major review: current aspects of ocular Behçet’s Disease in Japan. Ocul Immunol Inflamm. 2015;23(Suppl 1):S1–23. doi:10.3109/09273948.2014.981547.
   PubMed Web of Science ®Google Scholar
• Ishido T, Horita N, Takeuchi M, et al. Clinical manifestations of Behçet’s disease depending on sex and age: results from Japanese nationwide registration. Rheumatology (Oxford). 2017;56(11):1918–1927. doi:10.1093/rheumatology/kex285.
   PubMed Web of Science ®Google Scholar
• Mishima S, Masuda K, Izawa Y, Mochizuki M, Namba K. The eighth Frederick H. Verhoeff Lecture. presented by saiichi mishima, MD. Behçet’s disease in Japan: ophthalmologic aspects. Trans Am Ophthalmol Soc. 1979;77:225–279.
   PubMedGoogle Scholar
• Benezra D, Cohen E. Treatment and visual prognosis in Behçet’s disease. Br J Ophthalmol. 1986;70:589–592.
   PubMed Web of Science ®Google Scholar
• Miyake M, Sunagawa M, Okinami S. Behçet’s disease characteristics more than 10 years after diagnosis. Nihon Ganka Kiyo (Folia Ophthalmol Jpn). 1997;48:707–712. Japanese
   Google Scholar
• Nakahara H, Kaburaki T, Takamoto M, et al. Statistical analyses of Endogenous Uveitis Patients (2007–2009) in central Tokyo area and comparison with previous studies (1963–2006). Ocul Immunol Inflamm. 2015;23(4):291–296. doi:10.3109/09273948.2014.920036.
   PubMed Web of Science ®Google Scholar
• Yoshida A, Kawashima H, Motoyama Y, et al. Comparison of patients with Behçet’s disease in the 1980s and 1990s. Ophthalmology. 2004;111:810–815. doi:10.1016/j.ophtha.2003.07.018.
   PubMed Web of Science ®Google Scholar
• Kump LI, Moeller KL, Reed GF, Kurup SK, Nussenblatt RB, Levy-Clarke GA. Behçet’s disease: comparing 3 decades of treatment response at the National Eye Institute. Can J Ophthalmol. 2008;43(4):468–472. doi:10.3129/i08-080.
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Altunbas HH, Urgancioglu M. Uveitis in Behçet’s Disease: an analysis of 880 patients. Am J Ophthalmol. 2004;138(3):373–380. doi:10.1016/j.ajo.2004.03.022.
   PubMed Web of Science ®Google Scholar
• Cingu AK, Onal S, Urgancioglu M, Tugal-Tutkun I. Comparison of presenting features and three-year disease course in Turkish Patients with Behçet Uveitis who presented in the early 1990s and the Early 2000s. Ocul Immunol Inflamm. 2012;20(6):423–428. doi:10.3109/09273948.2012.713159.
   PubMed Web of Science ®Google Scholar
• Chung YR, Lee ES, Kim MH, Lew HM, Song JH. Changes in ocular manifestations of Behçet disease in korean patients over time: A single-center experience in the 1990s and 2000s. Ocul Immunol Inflamm. 2015;23(2):157–161. doi:10.3109/09273948.2014.918154.
   PubMed Web of Science ®Google Scholar
• Behçet’s Disease Research Committee of Japan. The revised criteria of Behçet’s Disease. Ministry of Health and Welfare, Japan. 2003;11–13. ( Japanese)
   Google Scholar
• Kaburaki T, Namba K, Sonoda KH, et al. Behçet’s disease ocular attack score 24: evaluation of ocular disease activity before and after initiation of infliximab. Jpn J Ophthalmol. 2014;58(2):120–130. doi:10.1007/s10384-013-0294-0.
   PubMed Web of Science ®Google Scholar
• Ando K, Fujino Y, Hijikata K, Izawa Y, Masuda K. Epidemiological features and visual prognosis of Behçet’s disease. Jpn J Ophthalmol. 1999;43:312–317.
   PubMed Web of Science ®Google Scholar
• Hijikata K, Masuda K. Visual prognosis in Behçet’s disease: effects of cyclophosphamide and colchicine. Jpn J Ophthalmol. 1978;22:506–519.
   Web of Science ®Google Scholar
• Behçet’s Disease Research Committee of Japan. The protocol of treatment and prevention of Behçet’s Disease. Ministry of Health and Welfare, Japan. 1987;22–29. ( Japanese)
   Google Scholar
• Behçet’s Disease Research Committee of Japan. The manual of treatments for Behçet’s Disease. Ministry of Health and Welfare, Japan. 1995;49–51. ( Japanese)
   Google Scholar
• Yoshida A, Kaburaki T, Okinaga K, Takamoto M, Kawashima H, Fujino Y. Clinical background comparison of patients with and without ocular inflammatory attacks after initiation of infliximab therapy. Jpn J Ophthalmol. 2012;56(6):536–543. doi:10.1007/s10384-012-0182-z.
   PubMed Web of Science ®Google Scholar
• Mizushima Y, Matsumura N, Mori M, et al. Colchicine in Behçet’s disease. Lancet. 1977;2(8046):1037. doi:10.1016/S0140-6736(77)92945-2.
   PubMed Web of Science ®Google Scholar
• Keino H, Okada AA, Watanabe T, Taki W. Decreased ocular inflammatory attacks and background retinal and disc vascular leakage in patients with Behçet’s disease on infliximab therapy. Br J Ophthalmol. 2011;95:1245–1250. doi:10.1136/bjo.2010.194464.
   PubMed Web of Science ®Google Scholar
• Kogure M, Ohno Y, Shimakawa M. Treatment of Behçet disease. Rinsho Ganka (Jpn J Clin Ophthalmol). 1980;34:1017–1024. Japanese
   Google Scholar
• Ohno S, Nakamura S, Hori S, et al. Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behcet’s disease with refractory uveoretinitis. J Rheumatol. 2004;31:1362–1368.
   PubMed Web of Science ®Google Scholar
• Kirino Y, Ideguchi H, Takeno M, et al. Continuous evolution of clinical phenotype in 578 Japanese patients with Behçet’s disease: a retrospective observational study. Arthritis Res Ther. 2016 Oct 3;18(1):217. doi:10.1186/s13075-016-1115-x.
   PubMed Web of Science ®Google Scholar
• Sakane T, Takeno M, Suzuki N, Inaba G. Behçet’s disease. N Engl J Med. 1999;341(17):1284–1291. doi:10.1056/NEJM199910213411707.
   PubMed Web of Science ®Google Scholar
• Whitcup SM, Salvo EC Jr, Nussenblatt RB. Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behçet’s disease. Am J Ophthalmol. 1994;118:39–45.
   PubMed Web of Science ®Google Scholar
• Shibui H, Kawashima H, Kamata K. et al., Experience in the Treatment of Behçet’s disease at Jichi Medical School Hospital. J Eye. 1997; 14(11): 1723–1727. Japanese
   Google Scholar